HOME >> MEDICINE >> NEWS
Colic in infants linked to inability to digest apple juice, but not white grape juice

Drinking white grape juice instead of apple means no increased symptoms of crying, abdominal discomfort, or sleeplessness for infants with a history of colic

Miami, FL (May 7, 2002) Young babies with a history of colic are more likely to re-experience some of the symptoms of colic after drinking apple juice than after drinking white grape juice, according to research published in the May, 2002 issue of Pediatrics, the journal of the American Academy of Pediatrics. According to the study, the colicky infants fed apple juice experienced more crying and restlessness and slept significantly less as compared with colicky infants fed white grape juice. Colic is estimated to affect between ten and 25% of all infants in the United States.

"Our study showed that babies with a history of colic are especially sensitive to what kind of juice they drink," says Fima Lifshitz, M.D., chief of nutrition sciences of Miami Childrens Hospital and senior author of the study. "Previous studies have showed us that most young babies have a harder time digesting apple juice than white grape juice, so it makes sense that infants with colic would fare even worse when fed juice that is difficult to digest."

The double-blind study looked at 30 infants, ages 4 to 6 months, 16 of whom had a history of colic. The babies with a colic history were divided into two groups; one group was fed one serving of four ounces of white grape juice, the other group received the same amount of apple juice. The babies with no history of colic were also split into two groups; one group receiving white grape, the other receiving apple.

"We found that the babies with a history of colic who drank apple juice exhibited significantly more crying during the study, expended more energy, slept less, and were less able to digest the carbohydrates in the juices," explains study lead author, Debora Duro, M.D. "However, among the babies who drank white grape juice, there was n
'"/>

Contact: Julie McQuain
Julie@jmpr.com
212-477-0472
JMPR Associates, Inc.
6-May-2002


Page: 1 2

Related medicine news :

1. How Can Parents Treat Colic In Their Babies?
2. UMaine study looks at infants and chronic nighttime crying
3. Hospital acquired infections present major problem for infants in developing countries
4. Cigarette smoke worsens respiratory infections in infants
5. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
6. Brain tumor with dismal prognosis in infants can be cured in older children
7. Infection in ELBW infants linked with poor neurodevelopmental, growth outcomes
8. Infection puts extremely low birth weight infants at risk for developmental delays
9. Infections in low-birth-weight infants are associated with impaired neurodevelopment and growth
10. Developmental issues among triplet infants
11. Premature infants with lung disease may continue to need replacement substance to ease breathing

Post Your Comments:
(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: